Skip to main content

Table 1 Demographic and baseline characteristics

From: A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand

 

ALN* (n = 245)

MAS3** (n = 245)

Maela

100

100

Mawker Tai

145

145

Males, no. (%)

172 (70)

164 (67)

Age, years

  

Mean (SD)

23.2 (14.6)

23.6 (15.1)

Range

3–70

2–72

Age group, no. (%)

  

<5

10 (4.1)

8 (3.3)

5–14

81 (33.1)

75 (30.6)

>14

154 (62.9)

162 (66.1)

Weight, kg

  

Mean (SD)

42.4 (14.5)

42.3 (15.0)

Range

10–77

10–78

Temperature, °C

  

Mean (SD)

37.7 (1.0)

37.8 (1.1)

Range

35.6–40.5

35.9–41.0

Fevera, no (%)

136 (55.5)

142 (58.0)

Haematocrit, %

  

Mean (SD)

36.7 (5.9)

36.4 (5.8)

Range

21–52

20–51

Geometric mean (range)

8,047

7,570

parasite count (μl-1)

(32–198,789)

(16–198,789)

Hepatomegaly, no (%)

48 (19.6)

50 (20.4)

Splenomegaly, no (%)

70 (28.6)

57 (23.3)

  1. * ALN = artemether-lumefantrine, ** MAS3 = artesunate-mefloquine aTympanic temperature ≥ 37.5°C